Developing monitoring

The Finnish Cancer Registry systematically collects, analyses and interprets data on cancer and cancer screening.

It actively participates in joint Nordic projects on cancer and screening statistics. Monitoring is being developed in new areas, such as inequality and screening tests. New areas are also emerging, as the registry’s knowledge base expands through text mining and cancer quality registry research. The monitoring of cancer burden risk factors and screening indicators is being developed in EU projects.

Finnish Cancer Registry research related to this focal area:

Cervical cancer screening is undergoing a major transition as HPV tests replace traditional cytological tests. Currently, triage methods (i.e., confirmatory tests) for positive HPV tests cause excessive referral loads and overdiagnosis of cervical cancer precursors, leading to unnecessary precursor treatments. This project aims to investigate how different triage methods can reduce the harms of HPV screening while maintaining or improving screening sensitivity.

The primary aim of this research is to examine the implementation and outcomes of cancer treatment in Finland. The results will be used to develop a national cancer quality registry as part of the current national cancer registry. The research project data will be used to investigate the prerequisites for initiating and establishing a cancer quality registry for all types of cancer. The study will develop the first national cancer treatment quality indicators and test them on a selected, specifically defined patient population.

The research is being carried out as a collaboration between the Cancer Society of Finland (Finnish Cancer Registry), the Finnish Institute for Health and Welfare (THL), and the National Cancer Center (FICAN).